Unlock instant, AI-driven research and patent intelligence for your innovation.

Peptoid compounds containing tertiary leucine and preparation method and application of peptoid compounds containing tertiary leucine

A technology for tert-leucine and compounds, which is applied in the field of peptoid compounds containing tert-leucine and its preparation and application, can solve problems such as adverse reactions and drug resistance, and achieve good spatial matching effects

Active Publication Date: 2019-05-31
XI AN JIAOTONG UNIV
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Small molecule tyrosine kinase inhibitors targeting Bcr-Abl are currently on the market, but there are problems such as drug resistance and other clinical adverse reactions.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Peptoid compounds containing tertiary leucine and preparation method and application of peptoid compounds containing tertiary leucine
  • Peptoid compounds containing tertiary leucine and preparation method and application of peptoid compounds containing tertiary leucine
  • Peptoid compounds containing tertiary leucine and preparation method and application of peptoid compounds containing tertiary leucine

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0032] see figure 1 , the preparation method of the peptoid compound containing tert-leucine of above-mentioned structure, comprises the following steps:

[0033] 1) Acylation of 5-bromo-2-aminopyridine with the corresponding acid chloride compound to prepare acylated 5-bromo-2-aminopyridine;

[0034] The specific process of the described step 1) is: dissolving 5-bromo-2-aminopyridine in anhydrous dichloromethane, adding triethylamine, and slowly adding the corresponding acid chloride compound dropwise to the above solution under ice-bath conditions After the dropwise addition was completed, the ice bath was removed and the reaction was carried out at room temperature for 12 hours. After the reaction, add dichloromethane to dilute, wash with water, wash with saturated sodium bicarbonate, wash with saturated sodium chloride, dry over anhydrous sodium sulfate, distill under reduced pressure, and separate by column chromatography to obtain a white solid, which is the acylated 5-...

Embodiment 1

[0048] A peptoid compound containing tert-leucine, R is , the preparation method is as follows:

[0049] 1) Synthesis of N-(5-bromopyridin-2-yl)acetamide: 5-bromo-2-aminopyridine (5.19 g, 30 mmol) was dissolved in 100 ml of anhydrous dichloromethane, and 20 ml of triethylamine was added. Under the condition of ice bath, acetyl chloride (2.54ml) was slowly added dropwise to the above solution. After the dropwise addition was completed, the ice bath was removed, and the mixture was raised to room temperature to react overnight (reaction 12h). After the reaction was finished, dichloromethane was added for dilution, washed with water (30ml×3), saturated NaHCO 3 Solution washing (30ml×3), saturated NaCl washing (30ml), organic phase anhydrous NaCl 2 SO 4 dry. Column chromatography separated 5.65 g of white solid with a yield of 88%. Mp 78-81℃; EI-MS(m / z):214[M] + .

[0050] 2) Synthesis of 4-(6-(acetylamino)pyridin-3-yl)benzoic acid: N-(5-bromopyridin-2-yl)acetamide (4.30g,...

Embodiment 2

[0056] A peptoid compound containing tert-leucine, R is , the preparation method is as follows:

[0057] 1) in N 2 Under protection, add thionyl chloride (36ml, 494mmol) dropwise to 5-bromonicotinic acid (5.00g, 24.7mmol). After the dropwise addition, heat to reflux for 2-3h until the solution is clear, and spin off the chloride under reduced pressure. Sulfoxide, a light yellow solid was obtained. The solid was dissolved in 30ml of anhydrous dichloromethane, and the reactive intermediate solution was slowly added dropwise to a solution of cyclopropylamine (3.77ml) in dichloromethane (30ml) in an ice bath. After the dropwise addition, it was raised to room temperature and reacted overnight. After the reaction, add 2mol / L K to the reaction system 2 CO 3 Solution 20ml. Separate the liquid to take the dichloromethane phase, extract the aqueous phase with dichloromethane (15ml × 3), combine the organic phases, anhydrous Na 2 SO 4 dry. Column chromatography separation and ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses peptoid compounds containing tertiary leucine and a preparation method and application of the peptoid compounds containing tertiary leucine. Target compounds are synthesized byreactions of acylation, Suzuki coupling, condensation and the like, a compound library is created, and the compounds are Bcr-Abl micromolecular tyrosine kinase inhibitors with novel molecular structures. By adoption of a fragment based drug design strategy, biphenyl pyridine serves as a hinge region binding fragment, L-tertiary leucine is introduced as flexible Linker to construct the library ofpeptoid micromolecular compounds with kinase inhibition activity, and the tyrosine kinase inhibitors with Bcr-Abl kinase inhibition activity are discovered through ADP-Glo kinase activity screening. According to kinase screening tests, the compounds have certain inhibition activity on Abl kinase and T315I mutant Abl kinase; according to cell proliferation tests, most of the compounds have certaininhibition activity on K562 cells.

Description

technical field [0001] The invention relates to a peptoid compound containing tert-leucine, a preparation method and application thereof. Background technique [0002] Chronic myeloid leukemia (CML) is a malignant clonal proliferative disease that occurs in bone marrow hematopoietic stem cells, accounting for 15% to 20% of adult leukemia patients. It is characterized by the detection of Ph chromosomes in CML patients. The Ph chromosome is a breakpoint aggregation cluster-Alberson (BCR-ABL) fusion gene formed by the reciprocal translocation of normal chromosome 22 and chromosome 9 in the human body. This fusion gene encodes Bcr that produces continuous activation of tyrosine kinase activity -Abl fusion protein. Small molecule tyrosine kinase inhibitors targeting Bcr-Abl are currently on the market, but they all have problems such as drug resistance and other clinical adverse reactions. Subsequently, the research and development of novel Bcr-Abl tyrosine kinase inhibitors ha...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D213/82C07D213/76A61P35/00
CPCY02P20/55
Inventor 张杰潘晓艳梁丽媛卢闻王嗣岑贺浪冲司茹王瑾
Owner XI AN JIAOTONG UNIV